---
title: "維昇藥業穩定價格期結束  超額配股權失效"
description: "維昇藥業－B 公佈，與全球發售有關的穩定價格期間已於 4 月 17 日結束。期間，穩定價格操作人摩根士丹利亞洲接連購買合共 170.77 萬股，每股作價介乎 58.35-68.8 元。最後一次購買日期 3 月 25 日，價格 60 元。此外，超額配售權並未行使，已於 4 月 17 日失效。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/236784421.md"
published_at: "2025-04-21T11:51:24.000Z"
---

# 維昇藥業穩定價格期結束  超額配股權失效

> 維昇藥業－B 公佈，與全球發售有關的穩定價格期間已於 4 月 17 日結束。期間，穩定價格操作人摩根士丹利亞洲接連購買合共 170.77 萬股，每股作價介乎 58.35-68.8 元。最後一次購買日期 3 月 25 日，價格 60 元。此外，超額配售權並未行使，已於 4 月 17 日失效。

維昇藥業－B(02561.HK) 公佈，與全球發售有關的穩定價格期間已於 4 月 17 日結束。期間，穩定價格操作人摩根士丹利亞洲接連購買合共 170.77 萬股，每股作價介乎 58.35-68.8 元。最後一次購買日期 3 月 25 日，價格 60 元。此外，超額配售權並未行使，已於 4 月 17 日失效。

### Related Stocks

- [02561.HK - 維昇藥業-B](https://longbridge.com/zh-HK/quote/02561.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| China NMPA Approves Visen Pharmaceuticals' Lonapegsomatropin for Pediatric Growth Failure | China NMPA Approves Visen Pharmaceuticals' Lonapegsomatropin for Pediatric Growth Failure | [Link](https://longbridge.com/zh-HK/news/273687874.md) |
| Brewdog co-founder to plough millons into rescue bid for the struggling brewer | James Watt, co-founder of Brewdog, plans to invest £10m of his own money in a rescue bid for the struggling craft brewer | [Link](https://longbridge.com/zh-HK/news/276512447.md) |
| 03:19 ETPureHealth Research Supplements for Lymphatic System Feature Dandelion and Burdock Root to Reduce Swelling | PureHealth Research has introduced supplements for lymphatic system support featuring Dandelion and Burdock Root, aimed  | [Link](https://longbridge.com/zh-HK/news/276507565.md) |
| 7 days until ticket prices rise for TechCrunch Disrupt 2026 | Super Early Bird pricing for TechCrunch Disrupt 2026 ends on February 27 at 11:59 p.m. PT, offering savings of up to $68 | [Link](https://longbridge.com/zh-HK/news/276516270.md) |
| Towle & Co. Makes New $8.42 Million Investment in TD SYNNEX Corporation $SNX | Towle & Co. has made an $8.42 million investment in TD SYNNEX Corporation, acquiring 51,410 shares in the 3rd quarter. T | [Link](https://longbridge.com/zh-HK/news/276514810.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。